Holen Sie sich die Stockscreener-App
31.76
3.18%
0.98
Handel nachbörslich:
31.80
0.04
+0.13%
Schlusskurs vom Vortag:
$30.78
Offen:
$30.17
24-Stunden-Volumen:
968.16K
Relative Volume:
1.14
Marktkapitalisierung:
$1.39B
Einnahmen:
$656.32M
Nettoeinkommen (Verlust:
$-164.17M
KGV:
-10.66
EPS:
-2.9794
Netto-Cashflow:
$12.90M
1W Leistung:
+5.48%
1M Leistung:
+18.86%
6M Leistung:
-36.48%
1J Leistung:
-37.77%
1-Tages-Spanne:
$30.15
$32.34
1-Wochen-Bereich:
$29.79
$32.34
52-Wochen-Spanne:
$23.91
$63.58
Azenta Inc Stock (AZTA) Company Profile
Firmenname
Azenta Inc
Sektor
Telefon
(978) 262-2400
Adresse
200 SUMMIT DRIVE, BURLINGTON
Vergleichen Sie AZTA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AZTA
Azenta Inc
|
31.76 | 1.39B | 656.32M | -164.17M | 12.90M | -2.9794 |
|
ISRG
Intuitive Surgical Inc
|
537.99 | 189.82B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
177.67 | 49.98B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
89.02 | 44.00B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
256.26 | 37.05B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
222.42 | 16.36B | 2.90B | 467.20M | 306.90M | 6.37 |
Azenta Inc Stock (AZTA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-18 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2024-04-04 | Eingeleitet | Jefferies | Hold |
| 2024-02-01 | Bestätigt | B. Riley Securities | Buy |
| 2023-07-19 | Eingeleitet | Raymond James | Mkt Perform |
| 2023-05-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-02-09 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-03-31 | Fortgesetzt | B. Riley Securities | Buy |
| 2022-03-21 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Azenta Inc Aktie (AZTA) Neueste Nachrichten
Azenta Inc (AZTA) Trading 3.24% Higher on Jun 18 - GuruFocus
Shareholders in Azenta (NASDAQ:AZTA) have lost 59%, as stock drops 3.6% this past week - Yahoo Finance
SG Americas Securities LLC Has $1.07 Million Stock Position in Azenta, Inc. (NASDAQ:AZTA) - Defense World
GAMMA Investing LLC Increases Stake in Azenta, Inc. (NASDAQ:AZTA) - Defense World
California State Teachers Retirement System Sells 5,299 Shares of Azenta, Inc. (NASDAQ:AZTA) - Defense World
Azenta, Inc. (NASDAQ:AZTA) Shares Acquired by Deutsche Bank AG - Defense World
Cetera Investment Advisers Sells 539 Shares of Azenta, Inc. (NASDAQ:AZTA) - Defense World
Millennium Management LLC Purchases 17,899 Shares of Azenta, Inc. (NASDAQ:AZTA) - Defense World
Is Now An Opportune Moment To Examine Azenta, Inc. (NASDAQ:AZTA)? - Yahoo
Azenta, Inc. (NASDAQ:AZTA) Position Lessened by Man Group plc - Defense World
Enhance Laboratory Efficiency with Azenta’s CryoPod Carrier - Lab Manager
Ameriprise Financial Inc. Increases Holdings in Azenta, Inc. (NASDAQ:AZTA) - Defense World
Captrust Financial Advisors Acquires 2,026 Shares of Azenta, Inc. (NASDAQ:AZTA) - Defense World
The Manufacturers Life Insurance Company Has $447,000 Holdings in Azenta, Inc. (NASDAQ:AZTA) - Defense World
Azenta Announces Leadership Change with New General Counsel - TipRanks
Azenta Life Sciences and Form Bio Announce Strategic Partnership - GuruFocus
Northern Trust Corp Reduces Stake in Azenta, Inc. (NASDAQ:AZTA) - Defense World
Azenta (AZTA) Partners with Form Bio to Advance AAV Gene Therapy - GuruFocus
Azenta, Form Bio Launch Partnership for AAV Gene Therapy - marketscreener.com
Azenta Life Sciences And Form Bio Announce Strategic Partnership To Advance AAV Gene Therapy Development - marketscreener.com
Azenta, Form Bio announce strategic partnership - TipRanks
Azenta Life Sciences and Form Bio Announce Strategic Partnership to Advance AAV Gene Therapy Development - Nasdaq
Azenta, Inc. (NASDAQ:AZTA) Shares Sold by Voya Investment Management LLC - Defense World
Waters Corporation, Avantor, Azenta, Bio-Techne, and Elanco Stocks Trade Up, What You Need To Know - Yahoo Finance
Azenta to Participate in the UBS MedTech, Tools and Genomics Summit 2023 - Seeking Alpha
AZTA Q1 Earnings Call: Revenue Tops Expectations, Margin Progress Amid Macro Headwinds - FinancialContent
Price T Rowe Associates Inc. MD Increases Stock Holdings in Azenta, Inc. (NASDAQ:AZTA) - The AM Reporter
Needham & Company LLC Lowers Azenta (NASDAQ:AZTA) Price Target to $40.00 - Defense World
Balance Sheet Insights: Azenta Inc (AZTA)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX
Azenta targets 3%-5% organic growth and expands automation initiatives for FY2025 - MSN
Azenta, Inc. (NASDAQ:AZTA) Q2 2025 Earnings Call Transcript - Insider Monkey
First Trust Advisors LP Buys New Stake in Azenta, Inc. (NASDAQ:AZTA) - Defense World
Azenta Inc (AZTA) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Macroeconomic ... - Yahoo
Azenta (NASDAQ:AZTA) Hits New 1-Year Low Following Weak Earnings - Defense World
Azenta Inc (AZTA) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Macroeconomic Challenges - GuruFocus
Azenta, Inc. Reports Solid Q2 2025 Revenue Growth - TipRanks
Azenta, Inc. Reports Strong Q2 2025 Earnings - TipRanks
Azenta (AZTA) Price Target Lowered by Needham to $40 | AZTA Stoc - GuruFocus
Azenta Q2 2025 slides: Revenue growth returns with 400 bps margin expansion By Investing.com - Investing.com South Africa
Azenta (AZTA) Price Target Lowered by Needham to $40 | AZTA Stock News - GuruFocus
Transcript : Azenta, Inc., Q2 2025 Earnings Call, May 07, 2025 - marketscreener.com
Needham Adjusts Price Target on Azenta to $40 From $59, Keeps Buy Rating - marketscreener.com
Earnings call transcript: Azenta’s Q2 2025 results miss EPS forecast, stock rises - Investing.com Australia
Azenta Q2 2025 slides: Revenue growth returns with 400 bps margin expansion - Investing.com India
Azenta Fiscal Q2 Non-GAAP Earnings Fall, Revenue Rises - marketscreener.com
Azenta Surpasses Revenue Expectations in Q1 CY2025News and Statistics - IndexBox
Azenta (NASDAQ:AZTA) Beats Q1 Sales Targets - FinancialContent
Azenta (AZTA) Reports Q2 Earnings with Revenue Decline - GuruFocus
Azenta Reports Second Quarter Results for Fiscal 2025, Ended March 31, 2025 | AZTA Stock News - GuruFocus
Azenta Reports Second Quarter Results for Fiscal 2025, Ended March 31, 2025 - Quantisnow
Azenta expands PCR plate range - European Pharmaceutical Manufacturer
Finanzdaten der Azenta Inc-Aktie (AZTA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Azenta Inc-Aktie (AZTA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Zhou Ginger | SVP and General Manager, Genom |
Jan 31 '25 |
Buy |
45.88 |
417 |
19,132 |
27,916 |
| Pirogova Olga | SVP and CHRO |
Nov 19 '24 |
Sale |
40.07 |
548 |
21,958 |
19,373 |
| Hughes Violetta | VP, Chief Accounting Officer |
Nov 19 '24 |
Sale |
40.07 |
163 |
6,531 |
9,920 |
| Zhou Ginger | SVP and General Manager, Genom |
Nov 19 '24 |
Sale |
40.07 |
491 |
19,674 |
27,499 |
| Wang David Dong | SVP & GM, SMS |
Nov 19 '24 |
Sale |
40.07 |
348 |
13,944 |
24,114 |
| Joseph Jason | SVP, General Counsel, Secy. |
Nov 19 '24 |
Sale |
40.07 |
1,139 |
45,640 |
112,564 |
| Cueto Herman | EVP, Chief Financial Officer |
Nov 19 '24 |
Sale |
40.07 |
712 |
28,530 |
23,892 |
| Marotta John | President and CEO |
Nov 18 '24 |
Buy |
39.48 |
12,717 |
502,066 |
99,612 |
| Marotta John | President and CEO |
Nov 19 '24 |
Buy |
40.67 |
1,250 |
50,838 |
100,862 |
| Cornog William L | Director |
Nov 18 '24 |
Buy |
39.60 |
12,500 |
495,000 |
14,755 |
2.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):